Basel Medical Group Ltd
BMGL
$2.02
-$0.17-7.76%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 315.00K | 925.50K | 1.54M | 1.70M | 1.87M |
| Total Depreciation and Amortization | 460.80K | 427.30K | 392.30K | 383.00K | 373.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -380.50K | -223.30K | -65.10K | 106.80K | 280.00K |
| Change in Net Operating Assets | -1.50M | -757.30K | -1.60K | -631.50K | -1.27M |
| Cash from Operations | -1.10M | 372.10K | 1.86M | 1.56M | 1.25M |
| Capital Expenditure | -13.90K | -9.90K | -5.80K | -6.40K | -7.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 41.00K | 20.60K | -- | -- | -- |
| Cash from Investing | 27.10K | 10.70K | -5.80K | -6.40K | -7.00K |
| Total Debt Issued | 4.69M | 2.71M | 731.00K | -4.05M | -8.84M |
| Total Debt Repaid | -6.78M | -4.85M | -2.92M | 1.54M | 6.01M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 9.99M | 5.21M | 424.20K | 558.20K | 692.20K |
| Cash from Financing | 5.98M | 2.35M | -1.31M | -1.46M | -1.60M |
| Foreign Exchange rate Adjustments | -9.10K | -4.60K | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.89M | 2.73M | 545.00K | 96.60K | -355.70K |